1,062 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
JNJ Johnson & Johnson $139.96 $375.48B N/A
Article Searches
Medidata (MDSO) to be Acquired by Dassault for $5.8 Billion http://www.zacks.com/stock/news/429632/medidata-mdso-to-be-acquired-by-dassault-for-%2458-billion?cid=CS-ZC-FT-429632 Jun 14, 2019 - Dassault's acquisition of Medidata (MDSO) to close by 2019-end.
Pharma Stock Roundup: MRK Buys Small Cancer Biotech, RHHBY, MRK Drugs Get FDA Nod http://www.zacks.com/stock/news/429560/pharma-stock-roundup-mrk-buys-small-cancer-biotech-rhhby-mrk-drugs-get-fda-nod?cid=CS-ZC-FT-429560 Jun 14, 2019 - Key developments of the week include Merck's (MRK) deal to buy Tilos Therapeutics and FDA approval for Roche's (RHHBY) polatuzumab vedotin and Merck's Keytruda.
Why Investors Should Keep an Eye on the Oklahoma Opioid Trial Against Johnson & Johnson https://www.fool.com/features/specials/2019/06/07/why-investors-should-keep-an-eye-on-the-oklahoma-o.aspx?source=iedfolrf0000001 Jun 07, 2019 - The case, which is premised on a unproven legal theory, could impact the course of future opioid litigation.
Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster Headache http://www.zacks.com/stock/news/426292/pharma-stock-roundup-asco-update-fda-nod-for-llys-emgality-for-cluster-headache?cid=CS-ZC-FT-426292 Jun 07, 2019 - Pharma bigwigs present data from cancer studies at ASCO. Lilly's (LLY) CGRP Emgality gets FDA approval for episodic cluster headache in adults.
Celgene & Acceleron's BLA for Luspatercept Accepted by FDA http://www.zacks.com/stock/news/425862/celgene-accelerons-bla-for-luspatercept-accepted-by-fda?cid=CS-ZC-FT-425862 Jun 06, 2019 - Celgene (CELG) along with partner Acceleron submits application for luspatercept to the FDA.
Top Stock Reports for Johnson & Johnson, Chevron & Adobe http://www.zacks.com/research-daily/425505/top-stock-reports-for-johnson-johnson-chevron-adobe?cid=CS-ZC-FT-425505 Jun 06, 2019 - Top Stock Reports for Johnson & Johnson, Chevron & Adobe
10 Jaw-Dropping Numbers About Cancer Drug Development -- and What They Mean for Investors https://www.fool.com/investing/2019/06/05/10-jaw-dropping-numbers-about-cancer-drug-developm.aspx?source=iedfolrf0000001 Jun 05, 2019 - There's more good news with the fight against cancer than you might think.
Allergan's (AGN) Vraylar Gets FDA Nod for Bipolar Depression http://www.zacks.com/stock/news/421714/allergans-agn-vraylar-gets-fda-nod-for-bipolar-depression?cid=CS-ZC-FT-421714 May 29, 2019 - Allergan's (AGN) sNDA for Vraylar gets the FDA approval for the treatment of adult patients with major depressive episodes related to bipolar I disorder.
Teva Settles With Oklahoma, Shares Fall Following Downgrade http://www.zacks.com/stock/news/421544/teva-settles-with-oklahoma-shares-fall-following-downgrade?cid=CS-ZC-FT-421544 May 29, 2019 - Teva (TEVA) plummets after settlement with the state of Oklahoma in a litigation related to its role in opioid epidemic, resulting in a rating downgrade.
This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy https://www.fool.com/investing/2019/05/28/this-just-in-goldman-sachs-picks-4-big-pharma-stoc.aspx?source=iedfolrf0000001 May 28, 2019 - And the analyst really likes one in particular.

Pages: 123456...107

Page 1>